Eli Lilly on track to close with a higher market cap than J&J for first time since 1997

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Eli Lilly's stock has benefited from positive data in trials of an obesity drug and a treatment for Alzheimer's disease.

Eli Lilly & Co. was on track Friday to close with a greater market capitalization than Johnson & Johnson for the first time since October 1997, according to Dow Jones Market Data.

The stock LLY has been steadily rising since the release of positive data from a trial of a treatment for Alzheimer’s disease in early May, showing significant slowing of cognitive and function decline in patients with early symptomatic Alzheimer’s disease. For more, see: Eli Lilly stock jumps 5% after Alzheimer’s treatment slows disease progression in major trial

The degree of average weight reduction seen in the trial “has not been previously achieved” in similar Phase 3 trials, Dr. Jeff Emmick, senior vice president for product development at Lilly, said in a statement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedgeHe was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of Novo Nordisk and Sanofi.
Source: CNBC - 🏆 12. / 72 Read more »

Chicago protesters demanding access to FDA-approved Alzheimer's drugsThe Alzheimer's Association said every day without access to FDA-approved drugs, approximately 2,000 people reach a stage of the disease where they are no longer eligible for treatment.
Source: ABC7Chicago - 🏆 284. / 63 Read more »

Researchers Solve One Piece of Alzheimer’s PuzzleResearchers from Drexel University have shed new light on the role of the Tip60 enzyme in genetic disruptions that contribute to Alzheimer's disease. A team of scientists from Drexel University has discovered a new brain regulation mechanism that plays a crucial role in producing the proper prote
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

There's One Critical Thing We Can All Do to Keep Alzheimer's Symptoms at BayDeep sleep could be key to forestalling slow declines in brain health that may one day lead to Alzheimer's disease, the most common form of dementia.
Source: ScienceAlert - 🏆 63. / 68 Read more »